Clinical Trials Logo

Depression clinical trials

View clinical trials related to Depression.

Filter by:

NCT ID: NCT06110507 Recruiting - Clinical trials for Depressive Disorder, Treatment-Resistant

Chronic Anergic-anhedonic Depression Open Trial

CADOT
Start date: April 1, 2023
Phase:
Study type: Observational

A form of depression called 'dopamine-sensitive anergic-anhedonic syndrome is usually resistant to standard therapies (TRAD). On the other hand, they respond to dopaminergic approaches for which recommendations have been developed: DATA ('Dopaminergic Antidepressant Therapy Algorithm'). These are two stages starting with non-selective monoamineoxidase inhibitors (MAOI) or dopamine D2 receptor agonists (D2RAG) in 'monotherapy' (DATA1) and proposing to combine them in the event of a partial response (DATA2). The effectiveness of this approach in the management of TRAD has not yet been evaluated in routine care. The aim of this study is to evaluate the feasibility and effectiveness in routine care of the DATA recommendations in the management of TRAD presenting to a specialized consultation for resistant depression (short and long-term results).

NCT ID: NCT06109610 Recruiting - Depression Clinical Trials

Cognitive Behavioral Therapy on Adherence and Depression (CBT-AD) Among HIV/AIDS Patients

Start date: May 1, 2021
Phase: N/A
Study type: Interventional

Depression is highly comorbid with HIV/ AIDS and is associated with worse poor adherence to antiretroviral therapy (ART), and potentially to long-term immune functioning. Cognitive behavioral therapy may solve these problem.

NCT ID: NCT06109493 Recruiting - Depression Clinical Trials

Effects of an ACT-based Psychological Treatment in Patients With Chronic Kidney Disease

Start date: November 1, 2023
Phase: N/A
Study type: Interventional

Investigation of the efficacy of Acceptance and Commitment Therapy (ACT) for the psychological treatment of patients with chronic kidney disease.

NCT ID: NCT06109480 Recruiting - Depressive Disorder Clinical Trials

Effect of HD-tDCS Assisted ECT for Depression Disorder

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

To investigate the intervention effect of high definition transcranial direct current stimulation (HD-tDCS) assisted Electroconvulsive Therapy (ECT) for depressive disorder.

NCT ID: NCT06107491 Completed - Depression Clinical Trials

Preoperative Educational Videos on Maternal Stress Whose Children Received Congenital Heart Disease Surgery: During COVID-19 Panic

Start date: October 4, 2021
Phase: N/A
Study type: Interventional

During COVID-19 panic, we examined if educational digital video disk can reduce maternal uncertainty, anxiety and depression if their children undergo congenital heart disease surgery and when surgical or post-surgical complications occur. Compared to only routine education, adding digital video disk could decrease mothers' uncertainty and anxiety more after education, and until the day of discharge. Compared to only routine education, adding digital video disk could decrease mothers' uncertainty and anxiety more on the discharge day if their child had surgical or post-surgical complications.

NCT ID: NCT06107283 Recruiting - Clinical trials for Depression in Old Age

Study of the Reduction of the Prescriptions of Benzodiazepines and Related

BZD
Start date: March 1, 2023
Phase:
Study type: Observational

The significant consumption of Benzodiazepines and related drugs in the elderly outside of good practice recommendations is a major issue in the care of the elderly. Adverse effects have been the subject of numerous studies, leading to falls, addictions and even deaths. The general practitioner is often faced with long-term medication intake which is not consistent with a good benefit/risk balance, but stopping or reducing the dosage remains a problem in current practice. The Aftercare and Geriatric Rehabilitation services due to their operation (several weeks of hospitalization) seek to adapt the patient's therapies in order to obtain the most convincing benefit/risk balance possible. A reduction or withdrawal of treatments with Benzodiazepines or related drugs are therefore frequently initiated.

NCT ID: NCT06106763 Completed - Clinical trials for Hemodialysis Patients

Mandala Colouring On Anxiety, Depression, Pain And Quality of Life

MANDALA
Start date: September 1, 2022
Phase: N/A
Study type: Interventional

The research was conducted as an experimental research to determine the effect of mandala painting on pain, anxiety, depression and quality of life in patients undergoing hemodialysis.

NCT ID: NCT06105762 Not yet recruiting - Clinical trials for Major Depressive Disorder

Ketogenic Diet for Depression

KETO-MOOD
Start date: January 1, 2024
Phase: N/A
Study type: Interventional

Globally, it's estimated that around 300 million people are affected by depressive illness, and even with access to modern mental health care, long-term recovery is uncommon. Recently, there has been increasing interest in a promising intervention: the ketogenic diet. This diet restricts carbohydrate intake, promoting the breakdown of fats into circulating ketone bodies, which can act as an additional energy source for the brain, potentially reducing its reliance on glucose. While various sources of evidence suggest the potential benefits of the ketogenic diet for individuals with depression, robust clinical studies on its efficacy in depressed patients are lacking. Our goal is to conduct an eight-week, assessor-blinded, randomized controlled trial to investigate the therapeutic effects of a very low-carbohydrate, high-fat ketogenic diet compared to an active comparator diet in individuals with depression.

NCT ID: NCT06103760 Recruiting - Clinical trials for Major Depressive Disorder

Positioning of Esketamine Treatment in the Real-world Management of Depression

PoET
Start date: October 31, 2023
Phase: Phase 4
Study type: Interventional

The goal of this naturalistic, open label, single arm intervention study is to investigate the effects of Esketamine in treating depression.The main aims to answer are: - to investigate whether Esketamine is effective when added to ongoing antidepressant treatment - to identify patient characteristics that will determine a therapeutic response to Esketamine in real-world practice Participants will: - attend the clinic for supervised self-administration of intranasal Esketamine treatment - be observed for 2 hours following Esketamine administration including blood pressure monitoring - be asked to complete a battery of questionnaires - be reimbursed for travel expenses

NCT ID: NCT06102096 Recruiting - Anxiety Clinical Trials

Culturally Adapted iCBT for Arabic-speaking Refugee and Migrant Youth With Common Mental Health Problems

RAHA
Start date: November 27, 2023
Phase: N/A
Study type: Interventional

The aim of the current study is to explore whether culturally adapted internet-based cognitive behavioral therapy is effective in reducing the symptoms of various common mental health problems among Arabic-speaking refugee and migrant youth. We hypothesize that the symptoms of the psychological problems will significantly be reduced among youth who will receive iCBT compared to youth in the control group.